This site is intended for health professionals only

Home / News / Covid-19 / Serious shortage protocols for Fluoxetine and Salazopyrin extended to next year

Serious shortage protocols for Fluoxetine and Salazopyrin extended to next year

serious shortage protocols

By Isabel Shaw

07 Dec 2020

Two serious shortage protocols for Fluoxetine 30mg capsules and Salazopyrin EN-Tabs 500mg have been extended into next year, the Pharmaceutical Services Negotiating Committee (PSNC) has confirmed.

The serious shortage protocols (SSPs), which apply to all pharmacies in England, Wales and Northern Ireland, were introduced in October in response to ‘significant ongoing disruption’ to the supply of both drugs, PSNC said.

Both protocols were due to expire this month, but have been extended to 8 January 2021.

The SSPs provide pharmacists with procedures to follow for supplying a suitable alternative to patients.

Fluoxetine 30mg capsules were subject to a SSP in October last year, along with two other strengths of the antidepressant. However, the protocol for Fluoxetine 40mg capsules was withdrawn in Octobere after ‘sufficient stock’ of the drug had been made available to meet ‘normal demand’.

A full list of active SSPs has been published on the NHS Business Services Authority’s website.

Want news like this straight to your inbox?

Latest News

Public urged to be courteous with pharmacy teams over LFT shortage
Pharmacy industry leaders have asked the public to be patient and understanding with pharmacy teams...
long covid
1.3 million in the UK have long Covid, survey suggests
An estimated 1.3 million people in the UK currently have long Covid, a survey by...
free lft
Exclusive: Additional lateral flow test deliveries to pharmacies ‘should’ help meet demand
Community pharmacy sector leaders are hoping that a new supply of additional lateral flow tests...